Lipid-Nanoparticle-Based Genomic Medicines Market Size, Share, Forecast 2032 – iSay Research
Global Lipid-Nanoparticle Based Genomic Medicines Market: By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles); By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others); By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Others); By End-User (Hospitals, Biopharmaceuticals Companies, Research Institute); By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa) Global Industry Analysis, COVID-19 Impact, and Industry Forecast, 2018-2032.
Report Story